Fulcrum Therapeutics, Inc. (FULC)
NGM – Real Time Price. Currency in USD
3.71
+0.02 (0.54%)
Market open: Aug 12, 2026, 10:49 AM EDT
3.66
-0.03 (-0.81%)
Previous after-hours: Aug 11, 2026, 7:46 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
3.71
+0.02 (0.54%)
Market open: Aug 12, 2026, 10:49 AM EDT
3.66
-0.03 (-0.81%)
Previous after-hours: Aug 11, 2026, 7:46 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $48.5M significantly exceed its total debt $5.3M, ensuring strong financial flexibility
Total current assets $322.9M exceed Total current liabilities $10.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$16.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 31.35 | 6.05 | 10 | |
| Quick ratio | 31.35 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 6M | 3M | 80M | N/A | N/A |
| Gross Profit | 4M | 633K | 78M | -1M | -1M |
| Operating Income | -112M | -111M | -20M | -85M | -87M |
| Net Income | -110M | -97M | -10M | -75M | -85M |
| EBITDA | -110M | -108M | -18M | -83M | -85M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 62.18 | 5.5 |
| Next quarter | N/A | 65.59 | 5.5 |
| Current year | N/A | 40.15 | 5.5 |
| Next year | N/A | 51.42 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -38.57 | 19.35 | 13.92 | 7.0 |
| Y/Y | 999 | -51.35 | 10.71 | -16.28 | 4.8 |
| 3y average | 865.43 | -189.5 | -170.89 | -738.03 | 3.3 |
| 5y average | 529.32 | -123.71 | -100.26 | -456.67 | 3.3 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |